| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vp/ Chief Accounting Officer | See Remarks
1 company
Chopas James George is a Vp/ Chief Accounting Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 873 | $22.19 | $19,369.43 | -1.6% | +91.2% | - | |
| Sep 15, 2025 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 189 | $24.19 | $4,572.29 | -0.4% | +0.7% | - | |
| Sep 2, 2025 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 548 | $28.08 | $15,386.20 | -1.0% | -24.7% | - | |
| Mar 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 183 | $24.82 | $4,542.74 | -0.4% | -27.1% | -25.0% | |
| Jan 22, 2025 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 1,096 | $30.43 | $33,346.35 | -2.2% | -42.8% | -27.6% | |
| Jan 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 715 | $29.96 | $21,420.11 | -1.9% | -39.2% | -33.4% | |
| Jan 13, 2025 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 783 | $28.70 | $22,473.74 | -2.1% | -32.4% | -25.4% | |
| Sep 16, 2024 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 192 | $36.21 | $6,951.55 | -0.5% | -7.3% | -34.4% | |
| Sep 3, 2024 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 550 | $39.49 | $21,720.05 | -1.4% | -8.7% | -28.4% | |
| Mar 15, 2024 | APLS Apellis Pharmaceuticals, Inc. | Vp/ Chief Accounting Officer | Sell | 184 | $56.46 | $10,388.82 | -0.5% | -25.0% | -56.5% |